MedPath

Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Spectacle lenses
Registration Number
NCT03761758
Lead Sponsor
SightGlass Vision, Inc.
Brief Summary

Prospective, randomized, subject-masked 3-arm clinical study to assess the pediatric acceptability across three iterations of a novel spectacle lens design.

Detailed Description

This feasibility study was conducted to assess the performance of three experimental spectacle lens designs (spectacle lenses) in children between 6 and 9 years of age with myopia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Ages between 6 and 12 years
  • Myopia between -1.00 and -4.00 D
Exclusion Criteria
  • Participating in any clinical or other research study
  • Contact lens wearer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lens Design 3Spectacle lensesSpectacle lenses design 3, fitted into spectacle frames
Lens Design 1Spectacle lensesSpectacle lenses design 1, fitted into spectacle frames
Lens Design 2Spectacle lensesSpectacle lenses design 2, fitted into spectacle frames
Primary Outcome Measures
NameTimeMethod
Distance Visual Acuity2 weeks

Measurement of best corrected distance visual acuity

Subjective Responses2 weeks

Assessment of subject responses related to wear time of spectacles

Contrast Sensitivity2 weeks

Measurement of contrast sensitivity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre for Ocular Research & Education

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath